Reason for the notification
| |
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
Description of the financial instrument, type of instrument
|
Smith & Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Partial vesting of a Conditional Share Award granted on 23 May 2019 under the Smith & Nephew Global Share Plan 2010.
|
Date of Transaction
|
2021 - 05 - 24
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
|
Director / PDMR
|
Price (£)
|
Volume
|
Aggregated information
|
Total Ordinary Share Holding following the transaction *
|
Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
|
Myra Eskes (President APAC Region)
|
PDMR
|
15.6325
|
8,566
(of which 0 were sold and 8,566 retained)
|
N/A Single Transaction
|
26,898.32816 ordinary shares
|
0.00304%
|
Simon Fraser (President Advanced Wound Management)
|
PDMR
|
15.6325
|
2,599
(of which 636 were sold and 1,963 retained)
|
N/A Single Transaction
|
10,578.56333 ordinary shares
|
0.00120%
|
Attachments
- Original document
- Permalink
Disclaimer
Smith & Nephew plc published this content on 25 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2021 20:20:08 UTC.